INNOVATION
17 May, 2021
Research nurses are well placed to take control of informed consent during a clinical trial. This article discusses research nurses experience of this process during the coronavirus pandemic and how this can be used in the future. This article comes with a handout for a journal club discussion
Abstract
In this article we describe the steps we took to involve research nurses in the consent process during the exceptional period of clinical uncertainty, organisational upheaval and resource pressures seen during the first peak of the coronavirus pandemic in the UK. We show that nurses are well placed to coordinate the multidisciplinary team and have a unique set of professional skills that can be harnessed to improve the consent process, participants’ experiences and research outcomes.
DUTCH HOSPITAL EXPANDS ITS USE OF SECTRA S SOLUTION
Dutch hospital Alrijne Zorggroep has signed an enterprise imaging contract with international medical imaging IT and cybersecurity company, Sectra.
The contract is an expansion of an existing agreement that aims to broaden the use of the imaging solutions currently used in radiology to include cardiology.
Through the initiative, Alrijne has the possibility to further expand its use of the solution to include all medical imaging across the enterprise. Consolidating image management across Alrijne Zorggroep will reduce IT complexity and enable cross-discipline collaboration around patients.
“We have used Sectra’s solution for many years in radiology. It’s an intuitive solution with high availability that helps our radiologists to efficiently deliver high-quality care. Sectra has proven to be a partner that listens to its customers and clearly wants to meet both current and future needs. This was important in our decision to
UK coronavirus death toll rises by 13 with one in Birmingham
NHS England reports a further 11 COVID-19 hospital deaths occurring over 4 dates
14:02, 11 MAY 2021
Updated
A member of the vaccine team prepares a syringe with a dose of the AstraZeneca/Oxford Covid-19 vaccine, at an NHS Scotland vaccination centre set up at the Edinburgh International Conference Centre (EICC) in Edinburgh on February 1, 2021. - Britain is under a third national lockdown as it battles a new strain of the virus and has recorded more than 106,000 deaths from the disease the worst toll in Europe. (Photo by Jane Barlow / POOL / AFP) (Photo by JANE BARLOW/POOL/AFP via Getty Images)
UK coronavirus death toll rises by 14 with one in Birmingham
NHS England reported a further 12 Covid hospital deaths occurring over 6 dates
14:03, 7 MAY 2021
Latest news email updates straight to your inboxInvalid EmailSomething went wrong, please try again later.
Subscribe
When you subscribe we will use the information you provide to send you these newsletters. Your information will be used in accordance with ourPrivacy Notice.
Thank you for subscribingWe have more newslettersShow meSee ourprivacy notice
The UK coronavirus death toll has risen again on Friday with one further death in Birmingham.
Wales recorded zero deaths on May 7, according to Public Health Wales.
Share this article
Share this article
ResearchAndMarkets.com s offering.
This report offers strategic insights into the overall neurological diseases treatment market along with the market size and estimates for the duration 2019 to 2029. The said research study cover in-depth analysis of neurological treatment market segments based on type of drugs, diseases and different geographies further segmented by countries.
For the purpose of this study, the global neurological diseases treatment market is segmented on the basis of drug type into anticholinergic, antiepileptic, antipsychotic, hypnotic & sedative, analgesics, antihypertensive, anticoagulants, and others. Market size estimates and forecast for these segments for the period 2019 to 2029 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2021 to 2029, considering 2020 as the base year.